Öz

Hodgkin lymphoma (HL) in pediatric patients typically presents with mediastinal and supradiaphragmatic lymphadenopathy. Predominant skeletal involvement at diagnosis is exceptionally rare and represents a significant diagnostic challenge. We present the case of a 10-year-old child with a 6-month history of progressive weight loss, right hip pain, and gait disturbance. Initial imaging suggested non-malignant orthopedic conditions, but further studies revealed multifocal osteolytic bone lesions. A bone biopsy ultimately confirmed classical Hodgkin lymphoma. A Positron Emission Tomography/Computed Tomography (PET/CT) scan demonstrated intensely hypermetabolic osseous lesions with only minimal, disproportionately mild, nodal disease. Based on the Lugano classification, the patient was classified as Ann Arbor stage IV. The patient exhibited rapid clinical improvement following the initiation of OEPA (Vincristine, Doxorubicin, Etoposide, Prednisone) induction chemotherapy. This case underscores the importance of including lymphoproliferative disorders in the differential diagnosis of unexplained multifocal osteolytic lesions in children and highlights the critical role of timely tissue biopsy.

Anahtar Kelimeler: Bone, chemotherapy, child, extralymphatic, Hodgkin lymphoma

Kaynakça

  1. Jaffe E, Swerdlow SHCE, Campo E, Pileri S, Thiele J, Harris N, et al. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon: IARC. 2008.
  2. Eichenauer DA, Müller H, Sasse S, et al. Hodgkin lymphoma in children and adolescents - German Hodgkin Lymphoma Study Group. Dtsch Med Wochenschr. 2016;141(Suppl 2):S106-S116.
  3. Pizzo Phillip A, Poplack David G, Adamson Peter C, Blaney Susan M, Helman Lee J. “Principles and Practice of Pediatric Oncology (7th ed.)” (2015). Faculty Bookshelf. 2. https://hsrc.himmelfarb.gwu.edu/books/2
  4. Gaudio F, Pedote P, Asabella AN, et al. Bone involvement in Hodgkin’s lymphoma: clinical features and outcome. Acta Haematologica. 2018;140(3):178-82. https://doi.org/10.1159/000490489
  5. Cui L, Wang C, Lian H , et al. Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the bch‐lch 2014 protocol study. American Journal of Hematology. 2023;98(4):598–607. https://doi.org/10.1002/ajh.26829
  6. University of Giessen. European Network-Paediatric Hodgkin Lymphoma Study Group (EuroNet-PHL) Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents [Clinical trial registration] [Internet]. clinicaltrials.gov; 2026 Mar [cited 2026 May 19]. Available from: https://clinicaltrials.gov/study/NCT02684708
  7. Dörffel W, Rühl U, Lüders H, Claviez A, Albrecht M, Bökkerink J, Holte H, Karlen J, Mann G, Marciniak H, Niggli F, Schmiegelow K, Schwarze EW, Pötter R, Wickmann L, Schellong G. Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol 2013;31(12):1562-8. Doi: 10.1200/jco.2012.45.3266.
  8. Kluge R, Kurch L, Georgi T, Metzger M. Current Role of FDG-PET in Pediatric Hodgkin’s Lymphoma. Semin Nucl Med. 2017;47(3):242–57. doi:10.1053/j.semnuclmed.2017.01.001
  9. Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and Non-Hodgkin lymphoma: The Lugano classification. J Clin Oncol. 2014;32(27):3059-67. https://doi.org/10.1200/JCO.2013.54.8800
  10. Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood. 2005;106(7):2444-51. https://doi.org/10.1182/blood-2004-09-3759

Nasıl atıf yapılır

1.
Iddir S, Lounis B, Benlahreche Z batoul, Saidani A. Atypical presentation of Hodgkin lymphoma with predominant osseous involvement in a 10-year-old child. Turk J Pediatr Dis. 2026;Early View:1-4. https://doi.org/10.12956/TJPD.2025.1286